B.Riley Downgrades Allena Pharmaceuticals (ALNA) to Neutral
Tweet
Share
E-mailGet Alerts ALNA Hot Sheet
Price: $0.08 --0%
Rating Summary:
5 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
5 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani downgraded Allena Pharmaceuticals (NASDAQ: ALNA) from Buy to Neutral with a price target of $0.50 (from $3.00).
For an analyst ratings summary and ratings history on Allena Pharmaceuticals click here. For more ratings news on Allena Pharmaceuticals click here.
Shares of Allena Pharmaceuticals closed at $0.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
- Seaport Global Securities Downgrades JetBlue Airways (JBLU) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
